50200

Renal Biopsy; Percutaneous

CPT code 50200 describes a percutaneous renal biopsy, a minimally invasive diagnostic procedure performed to obtain a small tissue sample from the kidney for pathological examination. This procedure is crucial for diagnosing various kidney diseases, assessing disease progression, guiding treatment strategies, and evaluating the health of transplanted kidneys. Typically performed under local anesthesia, the physician uses imaging guidance, most commonly ultrasound or computed tomography (CT), to precisely locate the kidney and guide a biopsy needle to the target area. The patient is usually positioned prone or supine, depending on the kidney's location and the physician's preference. After skin sterilization and local anesthetic administration, a small incision or puncture is made. A specialized biopsy needle, often an automated 'tru-cut' or core biopsy needle, is advanced through the skin, muscle, and renal capsule into the kidney parenchyma. Multiple samples (usually 2-3 cores) are typically obtained to ensure adequate tissue for diagnosis. The samples are then placed in appropriate fixative solutions for histological, immunofluorescence, and electron microscopy studies. Post-procedure, pressure is applied to the biopsy site to minimize bleeding, and the patient is monitored closely for complications such as hemorrhage or pain. This diagnostic tool provides critical information that cannot be obtained through blood tests or urinalysis alone, allowing for definitive diagnosis and personalized management of kidney conditions. It is a fundamental procedure in nephrology, providing insights into the underlying causes of renal dysfunction, unexplained proteinuria, hematuria, and acute or chronic kidney injury.

Clinical Indications

  • Unexplained acute kidney injury (AKI) or rapidly progressive renal failure.
  • Unexplained chronic kidney disease (CKD) to determine etiology and prognosis.
  • Persistent proteinuria (e.g., nephrotic range proteinuria, >3.5 g/day) despite evaluation.
  • Persistent microscopic or macroscopic hematuria, especially with other signs of renal disease.
  • Systemic diseases with suspected kidney involvement (e.g., systemic lupus erythematosus, vasculitis, multiple myeloma).
  • Evaluation of renal allograft dysfunction or suspected rejection post-transplantation.
  • Assessment of therapeutic response to treatment for specific kidney diseases.
  • Suspected primary glomerular diseases (e.g., focal segmental glomerulosclerosis, membranous nephropathy, IgA nephropathy).
  • Suspected secondary glomerular diseases.
  • Diagnosis of renal masses if non-invasive imaging is inconclusive or surgical excision is not indicated.

Procedure Steps

  1. Patient counseling, informed consent, and pre-procedure laboratory evaluation (e.g., coagulation profile, complete blood count).
  2. Patient positioned appropriately, typically prone, but may be supine or lateral depending on kidney location and access.
  3. Sterile preparation and draping of the biopsy site (usually the flank or back).
  4. Administration of local anesthetic (e.g., lidocaine) to the skin, subcutaneous tissue, muscle layers, and renal capsule.
  5. Real-time imaging guidance (ultrasound or CT) used to localize the kidney and plan the needle trajectory, avoiding major vessels or other organs.
  6. A small skin incision is made with a scalpel to facilitate needle entry.
  7. The biopsy needle (e.g., automated spring-loaded biopsy device) is advanced under continuous imaging guidance to the renal cortex.
  8. Multiple tissue cores (typically 2-3) are obtained, ensuring adequate cortical tissue for pathological analysis.
  9. Needle removal and application of firm manual pressure to the biopsy site to achieve hemostasis.
  10. Application of a sterile dressing.
  11. Post-procedure monitoring in a recovery area for several hours, including vital signs and inspection of the biopsy site for bleeding.
  12. Post-biopsy imaging (e.g., ultrasound) may be performed to rule out significant hematoma or other complications.

Coding Guidelines

  • CPT code 50200 describes the percutaneous renal biopsy procedure itself and includes all components necessary for the biopsy, such as local anesthesia and facility overhead.
  • Imaging guidance (e.g., ultrasound, CT, fluoroscopy) is separately reportable when performed. For ultrasound guidance, report 76942 (Ultrasonic guidance for needle placement (e.g., biopsy, aspiration, injection, localization device), imaging supervision and interpretation). For CT guidance, report 77012 (Computed tomography guidance for needle placement (e.g., biopsy, aspiration, injection, localization device), radiological supervision and interpretation).
  • Code 50200 is specifically for percutaneous biopsy. Open renal biopsies (e.g., during surgery) would be coded differently (e.g., 50205).
  • When a biopsy of a transplanted kidney is performed percutaneously, 50200 is also the appropriate code, as the methodology is the same.
  • The professional component for interpreting the biopsy specimen is reported separately by the pathologist using appropriate pathology codes (e.g., 88305).
  • It is important to document the specific type of guidance used, the number of samples obtained, and any complications encountered.
  • Do not report 50200 with codes for nephrectomy or partial nephrectomy performed during the same encounter unless the biopsy is distinctly separate and clinically indicated prior to the definitive surgical procedure.

Associated ICD-10 Codes